These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1851869)

  • 21. Nucleotides in the polyomavirus enhancer that control viral transcription and DNA replication.
    Tang WJ; Berger SL; Triezenberg SJ; Folk WR
    Mol Cell Biol; 1987 May; 7(5):1681-90. PubMed ID: 3037332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further characterization of the interaction of polyoma virus and simian virus 40 with embryonal carcinoma cells.
    Hales K; Lehman JM
    Exp Mol Pathol; 1987 Aug; 47(1):48-58. PubMed ID: 3038593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a mutant polyoma that expresses in F9 embryonal carcinoma cells: morphology, tumorigenicity, and restriction enzyme analysis.
    Lehman JM; McMahon J; Hales K; Trevor K
    Exp Mol Pathol; 1987 Aug; 47(1):59-68. PubMed ID: 3038594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Point mutation in the polyomavirus enhancer alters local DNA conformation.
    Fujimura FK
    Nucleic Acids Res; 1988 Mar; 16(5):1987-97. PubMed ID: 2833724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional activity in 3T3, F9, and PCC4 embryonal carcinoma cells: a systematic deletion and linker-scanning study of the polyomavirus enhancer.
    Trotot P; Mechali F; Blangy D; Lacasa M
    Virology; 1994 Aug; 202(2):724-34. PubMed ID: 8030236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E1A represses wild-type and F9-selected polyomavirus DNA replication by a mechanism not requiring depression of large tumor antigen transcription.
    DePolo NJ; Villarreal LP
    J Virol; 1991 Jun; 65(6):2921-8. PubMed ID: 1851864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation near the polyoma DNA replication origin permits productive infection of F9 embryonal carcinoma cells.
    Fujimura FK; Deininger PL; Friedmann T; Linney E
    Cell; 1981 Mar; 23(3):809-14. PubMed ID: 6261957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcription enhancer factor-1 (TEF-1) DNA binding sites can specifically enhance gene expression at the beginning of mouse development.
    Mélin F; Miranda M; Montreau N; DePamphilis ML; Blangy D
    EMBO J; 1993 Dec; 12(12):4657-66. PubMed ID: 8223475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small and middle T antigens contribute to lytic and abortive polyomavirus infection.
    Türler H; Salomon C
    J Virol; 1985 Feb; 53(2):579-86. PubMed ID: 2578576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical and biological features of polyoma virus mutants able to infect embryonal carcinoma cell lines.
    Vasseur M; Katinka M; Herbomel P; Yaniv M; Blangy D
    J Virol; 1982 Sep; 43(3):800-8. PubMed ID: 6292462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A factor discriminating between the wild-type and a mutant polyomavirus enhancer.
    Kovesdi I; Satake M; Furukawa K; Reichel R; Ito Y; Nevins JR
    Nature; 1987 Jul 2-8; 328(6125):87-9. PubMed ID: 3037380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations of polyomavirus VP1 allow in vitro growth in undifferentiated cells and modify in vivo tissue replication specificity.
    Mezes B; Amati P
    J Virol; 1994 Feb; 68(2):1196-9. PubMed ID: 8289350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells.
    Kryszke MH; Piette J; Yaniv M
    Nature; 1987 Jul 16-22; 328(6127):254-6. PubMed ID: 3037385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. cis-acting sequences that control the level of viral DNA synthesis in the polyomavirus late region.
    Melucci-Vigo G; Ciotta C; Risuleo G
    J Virol; 1989 Nov; 63(11):4979-81. PubMed ID: 2552181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple domains in the polyomavirus B enhancer are required for productive infection of F9 embryonal carcinoma cells.
    Tseng RW; Fujimura FK
    J Virol; 1988 Aug; 62(8):2890-5. PubMed ID: 2839707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of composite DNA derived from L factor as a plasmid in mouse embryonal carcinoma (F9) cells.
    Nishimori K; Kohda T; Fujiwara J; Oishi M
    Mol Cell Biol; 1988 May; 8(5):2097-104. PubMed ID: 2838742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggregation between teratocarcinoma cells and preimplantation mouse embryos.
    Stewart C
    J Embryol Exp Morphol; 1980 Aug; 58():289-302. PubMed ID: 7441158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancer-mediated role for polyomavirus middle T/small T in DNA replication.
    Chen MC; Redenius D; Osati-Ashtiani F; Fluck MM
    J Virol; 1995 Jan; 69(1):326-33. PubMed ID: 7983726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of retrovirus gene expression in embryonal carcinoma cells.
    Akgün E; Ziegler M; Grez M
    J Virol; 1991 Jan; 65(1):382-8. PubMed ID: 1845898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retroviral mutants efficiently expressed in embryonal carcinoma cells.
    Franz T; Hilberg F; Seliger B; Stocking C; Ostertag W
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3292-6. PubMed ID: 3010288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.